Sign Up for Our E-Newsletter

What’s Happening?

My Story: Personalized Chemo Dosing

Posted on June 8, 2014

serum tube (2)

“I didn’t think I was doing that badly, but apparently I was losing ground and the side effects were getting worse.”

After nearly 11 years of ongoing health issues, my energy was fading fast. I’d seen doctor after doctor, specialist after specialist, but no one seemed to know what was wrong. By chance, I remembered that I’d had a colonoscopy back in 2000 and they’d found a polyp. I brought this up to my doctor and, combined with my symptoms, he scheduled me for a repeat colonoscopy. Read more

Webinar: Better Cancer Care Through Accurate and Personalized Chemotherapy Dosing

Posted on June 5, 2014

girl at comp

Learn how to achieve the ideal concentration of chemotherapy drug in your system through our upcoming webinar. We’re partnering with MyCare Diagnostics to bring you a discussion on better cancer care featuring Adrienne Choma, Co-founder and Chief Operating Officer of Saladax Biomedical Inc., the maker of My5-FU Chemotherapy Optimization Test.  Read more

Partner Spotlight: Abramson Cancer Center

Posted on June 3, 2014


The Partnership

In 2012 we were proud to name the Abramson Cancer Center at the University of Pennsylvania as a partner through our Blue Hope Partnership Program, an initiative providing funding to organizations that are making strides to knock colon cancer out of the top three cancer killers. Abramson Cancer Center is made up of a group of doctors and researchers who, through treatment and prevention, are working to eradicate cancer as a cause of human disease and suffering. Funds provided through our Blue Hope Partnership Program were put to use in 2012 when Abramson launched the University of Pennsylvania Health System’s Colorectal Cancer Screening Navigation Program. Read more

Colon Health Alert: FDA Approves First-Line Use of Vectibix®

Posted on May 28, 2014

Colon Health Alert_square

Amgen recently announced that the FDA has approved the use of Vectibix as a first-line treatment for colorectal cancer. Since 2006, Vectibix has been used as a second-line treatment and with this recent advancement, colorectal cancer patients now have an additional treatment option earlier in their diagnosis. Read more

Call It Like It Is: New Name for the Undy Series

Posted on May 13, 2014

Undy new name

Have you been participating in our Undy 5000 for years, but never knew what the 5000 was all about?  After hearing that the name “Undy 5000” didn’t resonate with a lot of people, we have some good news – we are excited to announce that the Colon Cancer Alliance’s signature Undy 5000 5K series will now be known as the Undy Run/Walk! Read more